ReviewDrug safety2009
A strategy for regulatory action when new adverse effects of a licensed product emerge.
Jeffrey K Aronson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewDrug safety2009
Jeffrey K Aronson et al.PubMed ↗Publisher ↗
No numbers read from the abstract.